Neurocrine Biosciences Logo

Neurocrine Biosciences

🇺🇸
NBIX
US64125C1099

Neurocrine Biosciences is a biopharmaceutical company that researches, develops, and markets innovative therapies for neurological, psychiatric, and rare endocrine diseases. The company focuses on improving patients' quality of life through scientific advancements and providing much-needed medicines.

Next Quarterly Earnings

Tuesday, November 3, 2026
CW 45
After-Hours
In 68 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 6, 2026

Stock Price

Frequently asked questions

When will Neurocrine Biosciences report its next quarterly earnings?

Neurocrine Biosciences is scheduled to report its next quarterly earnings on 11/03/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Neurocrine Biosciences last report quarterly earnings?

Neurocrine Biosciences last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 1.39 USD.

How does Neurocrine Biosciences stock react to earnings?

Across its last 4 earnings reports, Neurocrine Biosciences stock moved by ±11% on average the following day. The largest reaction was -18.5% on 02/06/2025; 1 of 4 reactions were positive.

How often has Neurocrine Biosciences beaten expectations?

Neurocrine Biosciences has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Neurocrine Biosciences earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$1.90
Actual:
Q2 2026
Missed
Estimate:$1.66
Actual:$1.39
Difference:-$0.27
Q1 2026
Beat
Estimate:$1.22
Actual:$1.91
Difference:+$0.69
Price reaction (1 day):+8.9 %
Price reaction (7 days):+15.4 %
Q4 2025
Missed
Estimate:$1.81
Actual:$1.48
Difference:-$0.33
Price reaction (1 day):-10.4 %
Price reaction (7 days):-6.6 %
Q3 2025
Beat
Estimate:$2.07
Actual:$2.17
Difference:+$0.10
Price reaction (1 day):-6.4 %
Price reaction (7 days):-2.8 %
Q1 2025
Beat
Estimate:$1.50
Actual:$1.65
Difference:+$0.15
Q4 2024
Estimate:
Actual:
Price reaction (1 day):-18.5 %
Price reaction (7 days):-22.4 %

Earnings statistics

Stock reaction to earnings

±11%
Avg. next-day move
-18.5%
Largest move (02/06/2025)
25%
Share of positive reactions
±11.8%
Avg. move after 7 days

Basis: price reactions to the last 4 report dates (close to close).

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
+4.4%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Neurocrine Biosciences
Ticker Symbol
NBIX
ISIN
US64125C1099
Country
🇺🇸
USA
Sector